Tickerplace logo

Tickerplace

Argenica Therapeutics Limited logo

AGNArgenica Therapeutics Limited

AGN Stock Price, Valuation & Chart | Argenica Therapeutics Limited

Compare
$0.180-0.01 (-7.69%)

At close · 03 Sept 2026, 05:35 am

Sector: HealthcareIndustry: BiotechnologyAGN intrinsic valueAGN calculated fair value vs priceWebsite
OverviewFinancialsDividendsRatios

AGN Historical price chart

AGN Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization23.12M
PE Ratio-2.36
EPS-0.08
Trading Volume65.76K
Today's High/Low0.2/0.18
Dividend Yield0.00
52 Week High/Low0.38/0.09
Shares Outstanding128.46M
AGN Financial Statement
AGN Analyst ratings
AGN Analysis & performance metrics

AGN Company profile

Argenica Therapeutics Limited engages in the research and development of a neuroprotective therapeutic drug in Australia. Its lead product candidate is ARG-007, a…

AGN Management team

Management
Emma WaldonCFO
Chief Financial Officer & Company Secretary
Liz Dallimore B.Sc., M.B.A., Ph.D.CEO
Chief Executive Officer, MD & Director
Bruno Philip Meloni
Chief Scientific Officer
Total 3 executives

AGN Frequently asked questions

What is Argenica Therapeutics Limited (AGN) Stock Price?

Current stock price of Argenica Therapeutics Limited (AGN) stock is $0.180. The stock price is -7.69% lower in the session. The intraday range can be seen from this page. Volume of Argenica Therapeutics Limited (AGN) stock is 65.76K.

Last updated at 03 Sept 2026, 05:35 am.

Why is the Argenica Therapeutics Limited (AGN) stock price going up or down today?

The stock price of Argenica Therapeutics Limited (AGN) can change with earnings, company news, and overall market sentiment. Argenica Therapeutics Limited operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Argenica Therapeutics Limited stock expensive at its current price?

Whether Argenica Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AGN on this page is -2.36. EPS on this page is -0.08. Compare those figures with peers and growth expectations before deciding if the current Argenica Therapeutics Limited price is justified.

How has the stock price of Argenica Therapeutics Limited (AGN) performed historically?

Historical performance for Argenica Therapeutics Limited (AGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AGN reacted to past earnings and market events.

Should I buy Argenica Therapeutics Limited (AGN) stock, at this price?

Buying Argenica Therapeutics Limited (AGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.